Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Trial ID or NCT#
NCT01034033
Status
RECRUITING
Purpose
The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.
Official Title
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Investigator(s)
James Ford
Medical oncologist,
Gastrointestinal specialist,
Cancer geneticist
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Allison W. Kurian, M.D., M.Sc.
Medical oncologist,
Breast specialist,
Cancer geneticist
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Daniel Rubin
Contact us to find out if this trial is right for you.
Contact
Meredith Mills
650-724-5223
View on ClinicalTrials.gov
